Author:
Abuelazm Mohamed T.,Elzeftawy Mohamed A.,Kamal Manar Ahmed,Badr Helmy,Gamal Mohamed,Aboulgheit Mahmoud,Abdelazeem Basel,Abd-elsalam Sherief,Abouzid Mohamed
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Malaria vaccines: preferred product characteristics and clinical development considerations. https://www.who.int/publications-detail-redirect/9789240057463. Accessed 10 Nov 2023.
2. Autoridad Nacional del Servicio Civil. World malaria report 2021. Angewandte Chemie International Edition, 6(11), 951–952. 2021;2013–5.
3. World Health Organization (WHO). Malaria. Geneva: World Health Organization; 2021.
4. WHO Global. World malaria report 2019. Brazzaville: WHO Regional Office for Africa; 2019. p. 1–232.
5. Sulyok Z, Fendel R, Eder B, Lorenz FR, Kc N, Karnahl M, et al. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial. Nat Commun. 2021;12:1–10.